Stocks and Investing Stocks and Investing
Fri, November 3, 2023
Thu, November 2, 2023

Andrew Mok Maintained (THC) at Strong Buy with Decreased Target to $94 on, Nov 2nd, 2023


Published on 2024-10-28 07:18:14 - WOPRAI, Andrew Mok
  Print publication without navigation


Andrew Mok of UBS, Maintained "Tenet Healthcare Corporation" (THC) at Strong Buy with Decreased Target from $104 to $94 on, Nov 2nd, 2023.

Andrew has made no other calls on THC in the last 4 months.



There are 9 other peers that have a rating on THC. Out of the 9 peers that are also analyzing THC, 1 agrees with Andrew's Rating of Hold. Following is the relevant analyst calls for the last 4 months


  • Scott Fidel of "Stephens & Co." Maintained at Hold with Increased Target to $89 on, Tuesday, August 1st, 2023


These are the ratings of the 8 analyists that currently disagree with Andrew


  • John Ransom of "Raymond James" Maintained at Strong Buy with Decreased Target to $90 on, Wednesday, November 1st, 2023
  • Ann Hynes of "Mizuho" Maintained at Strong Buy with Decreased Target to $77 on, Tuesday, October 31st, 2023
  • Ben Hendrix of "RBC Capital" Maintained at Buy with Decreased Target to $72 on, Tuesday, October 31st, 2023
  • Stephen Baxter of "Wells Fargo" Maintained at Buy with Decreased Target to $71 on, Friday, October 20th, 2023
  • Sarah James of "Cantor Fitzgerald" Maintained at Buy with Increased Target to $94 on, Thursday, September 14th, 2023
  • Jamie Perse of "Goldman Sachs" Maintained at Strong Buy with Increased Target to $98 on, Monday, August 14th, 2023
  • A.J. Rice of "Credit Suisse" Maintained at Buy with Increased Target to $98 on, Wednesday, August 2nd, 2023
  • Jason Cassorla of "Citigroup" Maintained at Strong Buy with Increased Target to $90 on, Tuesday, August 1st, 2023
Contributing Sources